FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely therapy and neurology, and concerns treating kinetosis. That is ensured by administering a pharmaceutical composition containing an activated potentiated form of the antibodies to brain-specific protein S-100 and an activated potentiated form of the antibodies to endothelial NO-synthase.
EFFECT: method provides the effective treatment of kinetosis ensured by the synergetic action of the ingredients of the composition.
11 cl, 16 tbl, 4 ex
Authors
Dates
2014-01-10—Published
2011-07-01—Filed